Prucalopride: safety, efficacy and potential applications

Cisapride: What can we learn from the rise and fall of a prokinetic?

(2011) Eamonn MM QUIGLEY   Journal of Digestive Diseases

Diagnosis and treatment of chronic constipation - a European perspective

(2011) J. Tack et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

(2010) J. F. JOHANSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies

(2010) M. Camilleri et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation

(2010) Cornelius E. J. Sloots et al.   DIGESTIVE DISEASES AND SCIENCES

Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

(2010) Jeffrey M. Johnston et al.   GASTROENTEROLOGY

Efficacy of Linaclotide for Patients With Chronic Constipation

(2010) Anthony J. Lembo et al.   GASTROENTEROLOGY

A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation

(2010) S. Müller-lissner et al.   NEUROGASTROENTEROLOGY AND MOTILITY

An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome

(2009)   AMERICAN JOURNAL OF GASTROENTEROLOGY

Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries

(2009) Kayi Y. Chan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study

(2009) m. camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Pharmacological management of constipation

(2009) a. v. emmanuel et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation – Quality of Life questionnaire in prucalopride (RESOLOR®) trials for chronic constipation

(2009) d. dubois et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Selected Interventions in Nuclear Medicine: Gastrointestinal Motor Functions

(2009) Suwebatu T. Odunsi et al.   SEMINARS IN NUCLEAR MEDICINE

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies

(2008) D. A. DROSSMAN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study

(2008) E. M. M. QUIGLEY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

T1322 Safety and Tolerability of Prucalopride (Resolor®) in Patients with Chronic Constipation: Pooled Data from Three Pivotal Phase III Studies

(2008) Jan F. Tack et al.   GASTROENTEROLOGY

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

(2008) J Tack et al.   GUT

American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice

(2008) m. camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

(2008) Michael Camilleri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation

(2007) John F Johanson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY